Search Results - "Da Costa Neves, Patrícia Cristina"

Refine Results
  1. 1

    Aptamers as Delivery Agents of siRNA and Chimeric Formulations for the Treatment of Cancer by Dinis Ano Bom, Ana Paula, da Costa Neves, Patrícia Cristina, Bonacossa de Almeida, Carlos Eduardo, Silva, Dilson, Missailidis, Sotiris

    Published in Pharmaceutics (16-12-2019)
    “…Both aptamers and siRNA technologies have now reached maturity, and both have been validated with a product in the market. However, although pegaptanib reached…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Recombinant yellow fever viruses elicit CD8+ T cell responses and protective immunity against Trypanosoma cruzi by Nogueira, Raquel Tayar, Nogueira, Alanderson Rocha, Pereira, Mirian Claudia Souza, Rodrigues, Maurício Martins, Neves, Patrícia Cristina da Costa, Galler, Ricardo, Bonaldo, Myrna Cristina

    Published in PloS one (19-03-2013)
    “…Chagas' disease is a major public health problem affecting nearly 10 million in Latin America. Despite several experimental vaccines have shown to be…”
    Get full text
    Journal Article
  4. 4
  5. 5

    TLR expression and NK cell activation after human yellow fever vaccination by da Costa Neves, Patrícia Cristina, de Souza Matos, Denise Cristina, Marcovistz, Rugimar, Galler, Ricardo

    Published in Vaccine (18-09-2009)
    “…Abstract The yellow fever vaccine is very effective with a single injection conferring protection for at least 10 years. Recent evidence suggests that the…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Initial development of biosimilar immune checkpoint blockers using HEK293 cells by Ramos, Michael Bernardes, Araújo, Anna Erika Vieira de, Pestana, Cristiane Pinheiro, Ano Bom, Ana Paula Dinis, Bastos, Renata Chagas, de Almeida Oliveira, Aline, da Costa Neves, Patrícia Cristina, da Silva Junior, Haroldo Cid

    Published in Protein expression and purification (01-06-2020)
    “…Antibodies that block interaction of immune checkpoint receptors with its ligands have revolutionized the treatment of several cancers. Despite the success of…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    The role of immune subtyping in glioma mRNA vaccine development by Guterres, Alexandro, Abrahim, Mayla, da Costa Neves, Patrícia Cristina

    Published in Immunotherapy (01-09-2023)
    “…Studies on the development of mRNA vaccines for central nervous system tumors have used gene expression profiles, clinical data and RNA sequencing from sources…”
    Get full text
    Journal Article
  17. 17

    Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug by de Brito E Cunha, Danielle, Frederico, Ana Beatriz Teixeira, Azamor, Tamiris, Melgaço, Juliana Gil, da Costa Neves, Patricia Cristina, Bom, Ana Paula Dinis Ano, Tilli, Tatiana Martins, Missailidis, Sotiris

    Published in Pharmaceuticals (Basel, Switzerland) (05-05-2022)
    “…The depth and versatility of siRNA technologies enable their use in disease targets that are undruggable by small molecules or that seek to achieve a refined…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20